315 related articles for article (PubMed ID: 16077922)
1. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
Int J Oncol; 2005 Sep; 27(3):721-30. PubMed ID: 16077922
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo.
Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
Br J Surg; 2005 Mar; 92(3):305-10. PubMed ID: 15672426
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
4. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mansel RE; Mason MD
Int J Mol Med; 2005 Oct; 16(4):723-8. PubMed ID: 16142411
[TBL] [Abstract][Full Text] [Related]
5. Potential implication of IL-24 in lymphangiogenesis of human breast cancer.
Frewer NC; Ye L; Sun PH; Owen S; Ji K; Frewer KA; Hargest R; Jiang WG
Int J Mol Med; 2013 May; 31(5):1097-104. PubMed ID: 23546515
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
Chen X; Xie Q; Cheng X; Diao X; Cheng Y; Liu J; Xie W; Chen Z; Zhu B
Cancer Sci; 2010 Nov; 101(11):2384-90. PubMed ID: 20825419
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer.
Ming J; Zhang Q; Qiu X; Wang E
Eur J Cancer; 2009 Mar; 45(5):866-73. PubMed ID: 19136250
[TBL] [Abstract][Full Text] [Related]
8. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
9. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor.
Yuanming L; Feng G; Lei T; Ying W
Arch Med Res; 2007 Jan; 38(1):106-12. PubMed ID: 17174733
[TBL] [Abstract][Full Text] [Related]
11. [Interleukin 7 and its receptor promote cell proliferation and induce lymphangiogenesis in non-small cell lung cancer].
Ming J; Zhang QF; Jiang YD; Jiang GC; Qiu XS
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):511-8. PubMed ID: 23157741
[TBL] [Abstract][Full Text] [Related]
12. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
13. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
Zhuo W; Luo C; Wang X; Song X; Fu Y; Luo Y
J Pathol; 2010 Nov; 222(3):249-60. PubMed ID: 20814900
[TBL] [Abstract][Full Text] [Related]
14. Anti-lymphangiogenesis effects of a specific anti-interleukin 7 receptor antibody in lung cancer model in vivo.
Jian M; Qingfu Z; Yanduo J; Guocheng J; Xueshan Q
Mol Carcinog; 2015 Feb; 54(2):148-55. PubMed ID: 24115038
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis.
Sipos B; Kojima M; Tiemann K; Klapper W; Kruse ML; Kalthoff H; Schniewind B; Tepel J; Weich H; Kerjaschki D; Klöppel G
J Pathol; 2005 Nov; 207(3):301-12. PubMed ID: 16161179
[TBL] [Abstract][Full Text] [Related]
16. The specific effect of 2-methoxyestradiol on lymphatic vascular endothelial cells.
Imai S; Yoshida Y; Okamura T; Nagano K; Abe Y; Yoshikawa T; Kamada H; Nakagawa S; Tsunoda S; Tsutsumi Y
Pharmazie; 2009 Mar; 64(3):214-6. PubMed ID: 19348346
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular mechanisms of lymphangiogenesis.
Al-Rawi MA; Mansel RE; Jiang WG
Eur J Surg Oncol; 2005 Mar; 31(2):117-21. PubMed ID: 15698725
[TBL] [Abstract][Full Text] [Related]
18. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma.
Zhang B; Wang J; Gao J; Guo Y; Chen X; Wang B; Gao J; Rao Z; Chen Z
J Cell Biochem; 2009 May; 107(1):134-43. PubMed ID: 19241443
[TBL] [Abstract][Full Text] [Related]
19. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 7 induces the growth of breast cancer cells through a wortmannin-sensitive pathway.
Al-Rawi MA; Rmali K; Mansel RE; Jiang WG
Br J Surg; 2004 Jan; 91(1):61-8. PubMed ID: 14716795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
